About the journal

Cobiss

Srpski arhiv za celokupno lekarstvo 2020 Volume 148, Issue 11-12, Pages: 706-710
https://doi.org/10.2298/SARH200215090M
Full text ( 653 KB)
Cited by


Glucose concentration monitoring using near-infrared spectrum of spent dialysis fluid in hemodialysis patients

Matović Valentina (University of Belgrade, Faculty of Mechanical Engineering, Belgrade, Serbia), vmatovic@mas.bg.ac.rs
Trbojević-Stanković Jasna (University of Belgrade, Faculty of Medicine, Belgrade, Serbia + Dr Dragiša Mišović - Dedinje University Hospital Center, Clinic of Urology, Belgrade, Serbia)
Jeftić Branislava ORCID iD icon (University of Belgrade, Faculty of Mechanical Engineering, Belgrade, Serbia)
Matija Lidija ORCID iD icon (University of Belgrade, Faculty of Mechanical Engineering, Belgrade, Serbia)

Introduction/Objective. Diabetic nephropathy leading to end-stage renal disease is a major health problem worldwide. Hemodialysis (HD) treatment is associated with glycemia variations. Diabetic patients on HD might benefit from a non-invasive online glycemia monitoring system. The aim of this study was to assess the glucose concentration from the matrix of the spent dialysate fluid using near-infrared (NIR) spectroscopy. Methods. Blood samples and spent dialysate were collected in the 15th minute of the HD treatment from 15 patients. The spent dialysis fluid was characterized by a NIR spectrometer in the range of 900–1300 nm. In order to apply the artificial neural network (ANN) and train it, the MATLAB NFTOOL program was used. The testing and training of the ANN were executed using the NIR spectrum of the spent dialysis fluid as input, and the glucose concentration as output. Results. A significant correlation in excess of 93% between the NIR spectrum of the spent dialysate and the blood glucose concentration (3–9 mmol/l) was found. Conclusions. NIR spectroscopy is a non-invasive and reliable method of glycemia monitoring which can be used in maintaining HD patients.

Keywords: Hemodialysis, Machine learning, spent dialysate, VIS-NIR, patient-specific